Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Cui, O. Anhenn, D. Theegarten, S. Ohshimo, F. Bonella, S. U. Sixt, J. Peters, J. Guzman, U. Costabel (Essen, Bochum, Germany). Increased in vitro production of IP-10/CXCL10 and MIG/CXCL9 by alveolar macrophages in sarcoidosis and EAA but not in IPF. Eur Respir J 2008; 32: Suppl. 52, 1877

Member's Comments

No comment yet.

Related content which might interest you: Increased SDF-1alpha production from alveolar macrophages in sarcoidosis in vitro Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008 Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002 The production of IL-18, IL-12 and TNF-alpha by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis Source: Eur Respir J 2003; 22: Suppl. 45, 177s Year: 2003 Cytokine production of alveolar macrophages is decreased by OR2AT4 Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Increased IL-16 production in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 107s Year: 2001 Human neutrophil peptides stimulate the production of TNF alpha by alveolar macrophages from patients with sarcoidosis Source: Annual Congress 2007 - Inflammatory cell biology Year: 2007 Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005 Increased IL-13 production in sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 314s Year: 2002 Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease Source: Eur Respir J 2006 Oct 01;28(4):824-831 Year: 2006 IgA inhibits LPS-induced IL-10 in human alveolar macrophages (HAM) Source: Eur Respir J 2005; 26: Suppl. 49, 585s Year: 2005 Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 LPS-induced TLR4 expression and cytokine release is impaired in monocytes and T-lymphocytes of COPD patients Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008 Endotoxin-induced IL-17 release by murine T-lymphocytes: interactions with airway macrophages Source: Eur Respir J 2001; 18: Suppl. 33, 408s Year: 2001 The effect of pentoxifylline on IL-12 and IL-18 release by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003 Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 Production of IL-12 and IL-18 by alveolar macrophages in acute and chronic hypersensitivity pneumonitis Source: Eur Respir J 2005; 26: Suppl. 49, 469s Year: 2005 Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9 Source: Eur Respir J 2002; 20: 1198-1205 Year: 2002 Chemokinome characterization in human lung macrophages following stimulation with Th2-type cytokines IL-4 or IL-13 Source: Annual Congress 2012 - Update on neutrophil and macrophage function in COPD Year: 2012 Induced sputum as a surrogate for BAL for the measurement of the monocyte/macrophage chemokines MCP-1 and MIP-1α in scleroderma fibrosing alveolitis Source: Eur Respir J 2006; 28: Suppl. 50, 309s Year: 2006 The upregulation of CD-11B expression on circulating neutrophils by CXCL8 and the involvement of CXCR1 in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 749s Year: 2006